Table 5 Correlation of expression of DcR3 and ERK1/2 with pathologic stages of tumour in gastric cancer patients
TNM stage | Cases | Positive number | Positive rate (%) | |||||
|---|---|---|---|---|---|---|---|---|
I | 6 | mRNA | Protein | +/+ | mRNA | Protein | +/+ | |
DcR3 | 1 | 1 | 1 | 16.7 | 16.7 | 16.7 | ||
ERK1 | 2 | 2 | 1 | 33.3 | 33.3 | 16.7 | P > 0.05 | |
ERK2 | 1 | 1 | 0 | 16.7 | 16.7 | 0.0 | ||
II | 17 | |||||||
DcR3 | 12 | 13 | 10 | 70.6 | 76.5 | 58.8 | ||
ERK1 | 14 | 14 | 11 | 82.4 | 82.4 | 64.7 | P > 0.05 | |
ERK2 | 10 | 12 | 9 | 58.8 | 70.6 | 52.9 | ||
III | 25 | |||||||
DcR3 | 21 | 21 | 21 | 84.0 | 84.0 | 84.0 | ||
ERK1 | 23 | 24 | 22 | 92.0 | 96.0 | 88.0 | P > 0.05 | |
ERK2 | 20 | 23 | 18 | 80.0 | 92.0 | 72.0 | ||
IV | 2 | |||||||
DcR3 | 2 | 2 | 2 | 100.0 | 100.0 | 100.0 | ||
ERK1 | 2 | 2 | 2 | 100.0 | 100.0 | 100.0 | P > 0.05 | |
ERK2 | 1 | 1 | 1 | 50.0 | 50.0 | 50.0 | ||